Difficulties in immunofixation analysis: a concordance study on the IFM 2007-02 trial

被引：0

作者：

H Caillon

T Dejoie

A-G Le Loupp

C Azoulay-Fauconnier

D Masson

P Moreau

M Denis

H Avet-Loiseau

机构：

[1] Biochemistry Laboratory,

[2] CHU Nantes,undefined

[3] Hematology Clinical,undefined

[4] CHU Nantes,undefined

[5] Hematology Laboratory,undefined

[6] CHU Nantes,undefined

来源：

Blood Cancer Journal | 2013年 / 3卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：e154 / e154

共 19 条

[1] Difficulties in immunofixation analysis: a concordance study on the IFM 2007-02 trial
Caillon, H.
Dejoie, T.
Le Loupp, A-G
Azoulay-Fauconnier, C.
Masson, D.
Moreau, P.
Denis, M.
Avet-Loiseau, H.
BLOOD CANCER JOURNAL, 2013, 3 : e154 - e154
[2] Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
Geoffrois, Lionnel
Martin, Laurent
De Raucourt, Dominique
Sun, Xu Shan
Tao, Yungan
Maingon, Philippe
Buffet, Joelle
Pointreau, Yoann
Sire, Christian
Tuchais, Claude
Babin, Emmanuel
Coutte, Alexandre
Rolland, Frederic
Kaminsky, Marie-Christine
Alfonsi, Marc
Lapeyre, Michel
Saliou, Marie
Lafond, Cedric
Jadaud, Eric
Gery, Bernard
Zawadi, Ayman
Tourani, Jean-Marc
Khoury, Cedric
Henry, Anne Rose
Hasbini, Ali
Guichard, Francois
Borel, Christian
Meert, Nicolas
Guillet, Pierre
Calais, Marie-Helene
Garaud, Pascal
Bourhis, Jean
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3077 - +
[3] Lenalidomide Maintenance After Stem-Cell Transplantation For Multiple Myeloma: Follow-Up Analysis Of The IFM 2005-02 Trial
Attal, Michel
Lauwers-Cances, Valerie
Marit, Gerald
Caillot, Denis
Facon, Thierry
Hulin, Cyrille
Moreau, Philippe
Mathiot, Claire
Roussel, Murielle
Payen, Catherine
Olivier, Pascale
Avet-Loiseau, Herve
BLOOD, 2013, 122 (21)
[4] Requirement for quality documentation concerning investigational medicinal product in a multicentric clinical trial. The experience of an institutional pharmacy with the IFM 2005-02 study
Guillemot, C.
Michenot, F.
Andissac, A.
Nobili-Escriva, C.
Attal, M.
Llau, M. E.
Neel, V.
Puisset, F.
Canonge, J. M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 224 - 224
[5] Acute Myeloid Leukemia and Antifungal Prophylaxis Era: Compliance of AML Centers, Invasive Fungal Infection (IFI) Classification, IFI Incidence and AML Outcomes from ALFA 2007-02 Study
Michallet, Mauricette
Sobh, Mohamad
Morisset, Stephane
Deloire, Alexandre
Raffoux, Emmanuel
De Botton, Stephane
Caillot, Denis
Chantepie, Sylvain
Girault, Stephane
Berthon, Celine
Bertoli, Sarah
Lepretre, Stephane
Leguay, Thibaut
Castaigne, Sylvie
Marolleau, Jean-Pierre
Pautas, Cecile
Malfuson, Jean Valere
Vey, Norbert
Gastaud, Lauris
Suarez, Felipe
Schmidt, Aline
Gressin, Remy
Bonmati, Caroline
Celli-Lebras, Karine
El-Hamri, Mohamed
Ribaud, Patricia
Dombret, Herve
Thomas, Xavier
Bergeron, Anne
BLOOD, 2019, 134
[6] Lenalidomide After Autologous Transplantation for Myeloma: First Analysis of a Prospective, Randomized Study of the Intergroupe Francophone Du Myelome (IFM 2005 02)
Attal, Michel
Harousseau, Jean Luc
Marit, Gerald
Caillot, Denis
Stoppa, Anne Marie
Benboubker, Lofti
Facon, Thierry
Hulin, Cyrille
Garderet, Laurent
Lamy, Thierry
Leyvraz, Serge
Doyen, Chantal
Michallet, Mauricette
Voillat, Laurent
Dumonte, Charles
Roussel, Murielle
Lauwers-Cances, Vallery
Cristini, Christelle
Escriva, Chantal
Petillon, Marie-Odile
Mathiot, Claire
Avet-Loiseau, Herve
Moreau, Philippe
BLOOD, 2009, 114 (22) : 220 - 221
[7] Maintenance treatment with thalidomide after autologous transplantation for myeloma: First analysis of a prospective randomized study of the intergroupe Francophone du Myelome (IFM 99 02).
Attal, M
Harousseau, JL
Leyvraz, S
Doyen, C
Hulin, C
Benboubker, L
Facon, T
Bourhis, JH
Garderet, L
Sotto, JJ
Michallet, M
Renaud, M
Voillat, L
Berthou, C
Marrit, G
Monconduit, M
Coiffier, B
Caillot, D
BLOOD, 2004, 104 (11) : 155A - 155A
[8] Prognostic Factors Affecting Progression Free Survival For Multiple Myeloma Patients Receiving Lenalidomide Maintenance After Autologous Transplantation. Follow-Up Analysis Of The IFM 2005-02 Trial
Marit, Gerald
Cances, Valerie Lauwers
Caillot, Denis
Facon, Thierry
Hulin, Cyrille
Moreau, Philippe
Mathiot, Claire
Roussel, Murielle
Payen, Catherine
Olivier, Pascale
Avet-Loiseau, Herve
Attal, Michel
BLOOD, 2013, 122 (21)
[9] Comparison of reduced-dose bortezomib plus thalidomide plus dexamethasone (vTD) to bortezomib plus dexamethasone (VD) as induction treatment prior to ASCT in de novo multiple myeloma (MM): Results of IFM2007-02 study
Moreau, P.
Facon, T.
Attal, M.
Doyen, C.
Hulin, C.
Marit, G.
Garderet, L.
Tiab, M.
Avet-Loiseau, H.
Harousseau, J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[10] Efficacy and Safety of Isa-KRd Induction Before Response-Adapted Consolidation in Transplant Eligible Newly Diagnosed Multiple Myeloma: an Interim Analysis of the IFM2020-02 MIDAS Study
Perrot, Aurore
Touzeau, Cyrille
Lambert, Jerome
Hulin, Cyrille
Caillot, Denis
Karlin, Lionel
Arnulf, Bertrand
Rey, Philippe
Garderet, Laurent
Macro, Margaret
Escoffre-Barbe, Martine
Gay, Julie
Basque, C. H. Cote
Chalopin, Thomas
Belhadj, Karim
de Colella, Jean Marc Schiano
Tiab, Mourad
Mohty, Mohamad
Kuhnowski, Frederique
Fontan, Jean
Manier, Salomon
Orsini-Piocelle, Frederique
Vincent, Laure
Leleu, Xavier
Corre, Jill
Moreau, Philippe
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S34 - S35

← 1 2 →